A Novel 3D Bioprinting Crosslinking Method Based on Solenoid Valve Control

Area of Science:

• Biomaterials Engineering
• Tissue Engineering
• 3D Bioprinting Technology

Background:

• Current bioink crosslinking methods in 3D bioprinting lack precise control, leading to unstable gels and potential cytotoxicity from residual agents.
• Achieving reliable scaffold formation with enhanced biological properties remains a significant challenge in the field.

Purpose of the Study:

• To develop and evaluate a novel, controlled crosslinking technique for bioinks using a solenoid valve system in a dual-mode 3D bioprinter.
• To improve the stability, mechanical properties, and cell viability of 3D bioprinted scaffolds.

Main Methods:

• Utilized sodium alginate bioink and calcium chloride crosslinking agent with a dual-mode 3D bioprinter.
• Employed extrusion-based printing with a solenoid valve for precise, localized injection of the crosslinking agent between printing layers.
• Controlled printing intervals and valve opening times to achieve desired scaffold thickness and crosslinking precision.

Main Results:

• The solenoid valve crosslinking technology significantly improved scaffold stability, hydrophilicity, swelling resistance, and degradation profiles.
• Enhanced mechanical properties and a notable increase in cell proliferation rate were observed due to reduced residual crosslinking agent.
• Demonstrated precise control over localized crosslinking for multilayered cell scaffold fabrication.

Conclusions:

• The developed solenoid valve crosslinking method offers precise control, enhancing the quality and biological performance of 3D bioprinted scaffolds.
• This advancement in controlled crosslinking is crucial for the maturation of 3D bioprinting and holds promise for dual-mode printing applications.
• The technology effectively addresses limitations of current methods, paving the way for more reliable and viable tissue engineering constructs.